CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
March 11, 2020—Ortho Clinical Diagnostics announced its Ortho Sera antigen blood phenotyping for patients in need of transfusions has been cleared to run on the Ortho Vision platform in the United States and Canada. Ortho Sera helps to test for more than 99 percent of commonly tested blood group antigens, with results generated in about 20 minutes.
“Ortho Clinical Diagnostics is proud to offer our laboratory partners solutions that help them quickly test donor blood for the most-needed phenotypes and confidently provide it to patients in need of transfusion,” Bob Stowers, head of Ortho’s transfusion medicine product portfolio, said in a press statement. “With the ability to analyze the most commonly tested antigens on a single Ortho Vision system and results in under 25 minutes, lab teams are better equipped to help clinicians focus on what matters most—treating their patients.”